APA (7th ed.) Citation

Manuel Sánchez Luna, Alejandro Pérez Muñuzuri, José Luis Leante Castellanos, César W. Ruiz Campillo, Ester Sanz López, Isabel Benavente Fernández, . . . Segundo Rite Gracia. (2019). An update of the recommendations of the spanish neonatology society for the use of paivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants. Elsevier.

Chicago Style (17th ed.) Citation

Manuel Sánchez Luna, Alejandro Pérez Muñuzuri, José Luis Leante Castellanos, César W. Ruiz Campillo, Ester Sanz López, Isabel Benavente Fernández, María Dolores Sánchez Redondo, and Segundo Rite Gracia. An Update of the Recommendations of the Spanish Neonatology Society for the Use of Paivizumab as Prophylaxis for Severe Infections Due to Syncytial Respiratory Virus in High Risk Infants. Elsevier, 2019.

MLA (9th ed.) Citation

Manuel Sánchez Luna, et al. An Update of the Recommendations of the Spanish Neonatology Society for the Use of Paivizumab as Prophylaxis for Severe Infections Due to Syncytial Respiratory Virus in High Risk Infants. Elsevier, 2019.